EdgarLookup
SC 13G

SCHEDULE FILED TO REPORT ACQUISTION OF BENEFICIAL OWNERSHIP

Company
BRAINSTORM CELL THERAPEUTICS INC.
Filed
February 6, 2014
Accession Number
0001387131-14-000409

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →